| Literature DB >> 29974003 |
Kazuhiro Nishida1, Alan Kawarai Lefor2, Tomohiro Funabiki1.
Abstract
INTRODUCTION: Transarterial chemoembolization (TACE) is the first-line therapy for patient with unresectable hepatocellular carcinoma (HCC). Although TACE is a generally safe procedure, major complications can be occurred. We describe a patient with rupture of HCC after TACE followed by gastric bleeding. CASEEntities:
Year: 2018 PMID: 29974003 PMCID: PMC6008880 DOI: 10.1155/2018/4576276
Source DB: PubMed Journal: Case Reports Hepatol ISSN: 2090-6595
Figure 1A contrast enhanced computed tomography scan of the abdomen showed iodized oil (arrow) and intraperitoneal free (curved arrow) air with a rupture of the HCC in segment II into the peritoneal cavity adjacent to the gastric wall (open arrow).
Figure 2A contrast enhanced computed tomography scan demonstrated gastric extraluminal compression by hepatocellular carcinoma (arrow) and extravasation of contrast medium into the stomach (open arrow).
Figure 3Emergent upper gastrointestinal endoscopy showed a submucosal tumor with central ulceration located on the anterior wall of the gastric body, corresponding to extraluminal compression by the hepatocellular carcinoma.
Figure 4Another submucosal tumor was found in the gastric fundus without ulcer formation.
Previously reported cases of HCC rupture after TACE.
| No. | Author | Year | Country | Age | Gender | Etiology | Cirrhosis | Tumor size (cm) | Location | Interval | Treatment | Outcome | Cause of death, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tu [ | 2016, 2013 | China | 45 | M | HBV | Present | 9 | Right | 10 | Conservative | Died | N.A |
| 2 | 61 | M | N.A. | Absent | 13 | Right | 6 | TAE | Alive | ||||
| 3 | 53 | M | HBV | Present | 11 | Right+Left | 7 | Conservative | Died | N.A. | |||
| 4 | 57 | M | HBV | Absent | 14 | Right+Left | 9 | TAE | Alive | ||||
| 5 | 64 | M | N.A. | Absent | 16 | Right+Left | 17 | Conservative | Alive | ||||
| 6 | 67 | F/M | N.A. | Absent | 16 | Right+Left | 13 | Conservative | Alive | ||||
| 7 | Singh Bhinder [ | 2015 | USA | 67 | M | alcohol, HCV | Present | 4 | VII | 1 | TAE | Alive | |
| 8 | Park [ | 2011 | Korea | 52 | M | HBV, alcohol | Present | 12.3 | VII | 30 | Conservative | Died | Hepatic failure, more than 1 year after TACE |
| 9 | Bruls [ | 2011 | Belgium | 78 | M | alcohol | Present | 7 | II, IV | 3 weeks | Conservative | Died | Tumor rupture, 2 month after TACE |
| 10 | Ritter [ | 2011 | Germany | 74 | M | alcohol | Present | 16 | III, IVb | 14 hours | Conservative | Died | Few hours after tumor rupture |
| 11 | Sun [ | 2010 | China | 28 | F | N.A. | N.A. | 13 | Right | 1 month | TAE | Alive | |
| 12 | 42 | F | N.A. | N.A. | 11 | Right | 3 | TAE | Alive | ||||
| 13 | 83 | F | N.A. | N.A. | 14 | Right | 5 month | TAE | Died | Respiratory failure, 1 week after rupture | |||
| 14 | 51 | M | N.A. | N.A. | 7 | Right | 16 hours | TAE | Alive | ||||
| 15 | 47 | M | N.A. | N.A. | 10 | Right | 7 months | TAE | Alive | ||||
| 16 | Nawawi [ | 2010 | Malaysia | 66 | M | alcohol | Present | 3.5 | N.A. | N.A. | N.A. | Died | Tumor rupture, 2 month after TACE |
| 17 | Reso [ | 2009 | Canada | 90 | M | N.A. | N.A. | 11 | Right | 4 hours | Conservative | Died | Respiratory failure, 16 days after TACE |
| 18 | Reichman [ | 2009 | USA | 53 | M | HBV | Present | 6 | VII, VIII | 6 hours | Laparotomy | Died | Shortly after tumor rupture |
| 19 | Battula [ | 2007 | UK | 61 | M | N.A. | Present | 11 | Right | 2 | Laparotomy | Died | Tumor rupture, 2 days after TACE |
| 20 | 69 | M | N.A. | Present | 13 | Right | 24 | Conservative | Alive | ||||
| 21 | Yeh [ | 2002 | Taiwan | 45 | M | HCV | Present | N.A. | IV-VIII | 2 month | Laparotomy | Died | Hepatic failure, one month after surgery |
HBV: hepatitis B virus: HCC: hepatocellular carcinoma: HCV: hepatitis C virus: TAE: transarterial embolization: TACE: transarterial chemoembolization: USA: the United States of America: UK: United Kingdom.